Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Dysphagia
Published in: Dysphagia 5/2016

01-10-2016 | Original Article

Drugs Related to Oropharyngeal Dysphagia in Older People

Authors: Marta Miarons, Lluís Campins, Elisabet Palomera, Mateu Serra-Prat, Mateu Cabré, Laia Rofes

Published in: Dysphagia | Issue 5/2016

Login to get access

Abstract

Scientific evidence on the impact of medication on the physiology of swallowing is scarce and mainly based on clinical case reports. To evaluate the association between oropharyngeal dysphagia (OD) and chronic exposure to medication in older patients admitted to the acute geriatric unit (AGU) of a secondary hospital, we performed a retrospective cross-sectional study of 966 patients admitted to an AGU from 2008 to 2011. We reviewed (a) diagnosis of OD (assessed with the volume-viscosity swallow test, V- VST); (b) chronic patient medication classified by anatomical, therapeutic, chemical codes; and (c) demographic and clinical data. A univariate analysis was performed to determine which medications were associated with OD. A multivariate analysis adjusting for confounding clinical factors was performed to identify which of those medications were independently associated with OD. The age of patients included was 85.3 ± 6.37 years and 59.4 % were women. A total of 41.9 % presented OD. We found a possible protective effect of beta blocking agents on OD after the multivariate analysis (OR 0.54, 95 % CI 0.35–0.85). None of the categories of drugs was associated with an altered swallowing function after adjusting for confounding variables. The present study is the first one to widely investigate the association between drugs and OD, increasing understanding of their association. The role of beta blockers in OD needs to be further studied as their potentially beneficial effects on the swallowing function in older patients could help to prevent complications.
Literature
1.
Nogueira D, Reis E. Swallowing disorders in nursing home residents: how can the problem be explained? Clinl Interv Aging. 2013;8:221–7.
2.
Cabré M, Serra-Prat M, Force L, Almirall J, Palomera E, Clavé P. Oropharyngeal Dysphagia is a risk factor for readmission for pneumonia in the very elderly persons: observational propsective study. J Gerontol A Biol Sci Med. 2014;69:330–7.
3.
Serra-Prat M, Hinojosa G, López D, et al. Prevalence of oropharyngeal dysphagia and impaired safety and efficacy of swallow in independently living older persons. J Am Geriatr Soc. 2011;59(1):186–7.PubMed
4.
Smithard D, O’Neill P, Parks C, et al. Complications and outcome after acute stroke. Does dysphagia matter? Stroke. 1996;27:1200–4.PubMed
5.
Finestone H, Greene-Finestone L, Wilson E, et al. Prolonged length of stay and reduced functional improvement rate in malnourished stroke rehabilitation patients. Arch Phys Med Rehabil. 1996;77:340–5.PubMed
6.
Teasell R, McRae M, Marchuk Y, et al. Pneumonia associated with aspiration following stroke. Arch Phys Med Rehabil. 1996;77:707–9.PubMed
7.
Murry T, Carrau R. Clinical management of swallowing disorders. 3rd ed. San Diego: Plural; 2012.
8.
Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003;124:328–36.PubMed
9.
Jean A. Brain stem control of swallowing: neuronal network and cellular mechanisms. Physiol Rev. 2001;81:929–69.PubMed
10.
Ertekin C, Aydogdu I. Neurophysiology of swallowing. Clin Neurophysiol. 2003;114:2226–44.PubMed
11.
Carl LL, Johnson PR. Drugs and dysphagia: how medications can affect eating and swallowing. 1st ed. Austin: Pro-Ed; 2006.
12.
13.
Dziewas R, Warnecke T, Schnabel M, et al. Neuroleptic-induced dysphagia: case report and literature review. Dysphagia. 2007;22(1):63–7.PubMed
14.
Sokoloff LG, Pavlakovic R. Neuroleptic-induced dysphagia. Dysphagia. 1997;12(4):177–9.PubMed
15.
Jt Stewart. Dysphagia associated with risperidone therpay. Dysphagia. 2003;18:274–5.
16.
Loeb M, Becker M, Eady A, et al. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J Am Geriatr Soc. 2003;51(7):1018–22.PubMed
17.
Fonda D, Schwarts J, Clinnick S. Parkinsonian medication one hour before meals improves symptomatic swallowing: a case study. Dysphagia. 1995;10:165–6.PubMed
18.
American Speech-Language-Hearing Association. Guidelines for speech-language pathologists performing videofluoroscopic swallowing studies. ASHA Suppl. 2004;24:77–92.
19.
Ebihara T, Takahashi H, Ebihara S, et al. Capsaicin troche for swallowing dysfunction in older people. J Am Geriatr Soc. 2005;53(5):824–8.PubMed
20.
Ebihara T, Sekizawa K, Nakazawa H, Sasaki H. Capsaicin and swallowing reflex. Lancet. 1994;341:432.
21.
Ebihara T, Ebihara S, Maruyama M, et al. A randomized trial of olfactory stimulation using black pepper oil in older people with swallowing dysfunction. J Am Geriatr Soc. 2006;54(9):1401–6.PubMed
22.
Rofes L, Arreola V, Martin A, Clavé P. Natural capsaicinoids improve swallow response in older patients with oropharyngeal dysphagia. Gut. 2013;62(9):1280–7.PubMed
23.
Rofes L, Arreola V, Martin A, Clavé P. Effect of oral piperine on the swallow response of patients with oropharyngeal dysphagia. J Gastroenterol. 2014;49(12):1517–23.PubMed
24.
Nakayama K, Sekizawa K, Sasaki H. ACE inhibitor and swallowing reflex. Chest. 1998;113(5):1425.PubMed
25.
Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet. 1998;352:1069.PubMed
26.
Cabré M, Serra-Prat M, Palomera E, Almirall J, Pallares R, Clavé P. Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing. 2010;39:39–45.PubMed
27.
Charlson M, Pompei P, Ales K, Mackenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMed
28.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–5.PubMed
29.
30.
Clavé P, Arreola V, Romea M, Medina L, Palomera E, Serra-Prat M. Accuracy of the volume-viscosity swallow test for clinical screening of oropharyngeal dysphagia and aspiration. Clin Nutr. 2008;27:806.PubMed
31.
Stewart JT. Reversible dysphagia associated with neuroleptic treatment. J Am Geriatr Soc. 2001;49:1260–1.PubMed
32.
Bashford G, Bradd P. Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. J Geriatr Psychiatry Neurol. 1996;9(3):133–5.PubMed
33.
Gonzalez F. Extrapyramidal syndrome presenting as dysphagia: a case report. Am J Hosp Palliat Care. 2008;25:398–400.PubMed
34.
Brandt N. Medications and dysphagia: How do they impact each other? Nutr Clin Pract. 1999;14:S27–30.
35.
Korsten M, Rosman A, Fishbein S, Shlein R, Goldberg H, Biener A. Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med. 1991;90(6):701–6.PubMed
36.
Sukys-Claudino L, Moraes W, Guilleminault C, Tufik S, Poyares D. Beneficial effect of donepezil on obstructive sleep apnea: a double-blind, placebo-controlled clinical trial. Sleep Med. 2012;13(3):290–6.PubMed
37.
Dantas R, Souza R. Dysphagia induced by chronic ingestion of benzodiazepine. Am J Gastroenterol. 1997;92(7):1194–6.PubMed
38.
Almirall J, Rofes L, Serra-Prat M, et al. Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly. Eur Respir J. 2013;41(4):923–8.PubMed
39.
Gaillard JM Benzodiazepines and GABA-ergic transmisión. In: Kryger MH, Roth T. Dement WC. (eds.) Principles and practie of sleep Medicine. Philadelphia. P. WB Saunders, 1989. pp. 213–218.
40.
Almirall J, Serra-Prat M, Baron F, Palomera E, Bolíbar I. The use of benzodiazepines could be a protective factor for community-acquired pneumonia in <60-year-old subjects. Thorax. 2013;68:965–6.
41.
Almirall J, Bolíbar I, Serra-Prat M, et al. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J. 2008;31:1274–84.PubMed
42.
Burks TN, Andres-Mateos E, Marx R, Mejias R, Van Erp C, Simmers JL, et al. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med. 2011;3:82ra37.PubMedPubMedCentral
43.
Murphy R, Gardiner P, Rousseau G, Bouvier M, Béliveau L. Chronic β-blockade increases skeletal muscle β-adrenergicreceptor density and enhances contractile force. J Appl Physiol. 1997;83(2):459–65.PubMed
44.
Bradley W, Daroff R, Fenichel G, Jankovic J. Neurology in clinical practice, the neurological disorders. JAMA. 2001;285(4):172.
45.
Shimizu T, Fujioka S, Otonashi H, Kondo M, Sekizawa K. ACE inhibitor and swallowing difficulties in stroke. A preliminary study. J Neurol. 2008;255(2):288–9.PubMed
46.
Arai T, Yasuda Y, Toshima S, Yoshimi N, Kashiki Y. ACE inhibitors and pneumonia in elderly people. Lancet. 1998;352:1937–8.PubMed
47.
Nakayama K, Sekizawa K, Sasaki H. ACE inhibitor and swallowing reflex. Chest. 1998;113:1425.PubMed
48.
Perez I, Smithard DG, Davies H, et al. Pharmacological treatment of dysphagia in stroke. Dysphagia. 1998;13:12–6.PubMed
49.
Ohkubo T, Chapman N, Neal B, Woodward M, Omae T, Chalmers J. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med. 2004;169(9):1041–5.PubMed
Metadata
Title
Drugs Related to Oropharyngeal Dysphagia in Older People
Authors
Marta Miarons
Lluís Campins
Elisabet Palomera
Mateu Serra-Prat
Mateu Cabré
Laia Rofes
Publication date
01-10-2016
Publisher
Springer US
Published in
Dysphagia / Issue 5/2016
Print ISSN: 0179-051X
Electronic ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-016-9735-5

Other articles of this Issue 5/2016

Dysphagia 5/2016 Go to the issue

Original Article

A Comparative Study Between Two Sensory Stimulation Strategies After Two Weeks Treatment on Older Patients with Oropharyngeal Dysphagia

Original Article

Cross-Cultural Adaptation and Validation of the Italian Version of SWAL-QOL

Original Article

Understanding the Viscosity of Liquids used in Infant Dysphagia Management

In Memoriam

Steven B. Leder, PhD

Review Article

Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review

Original Article

An Epidemiologic Study on Ageing and Dysphagia in the Acute Care Geriatric-Hospitalized Population: A Replication and Continuation Study